Bruker has announced the planned discontinuation of the IsoSpark and IsoLight platforms. Customers with questions about transition options and last-time-buy opportunities should contact their Bruker sales representative.

Row rect Shape Decorative svg added to bottom
Back to Webinars
The Future of Cellular Immunotherapy: Highly Automated Precision Medicine

Featured Speakers: Matthew Hewitt, PhD, Head of R&D (a.i.) and Clinical Development, Personalized Medicine, Lonza, and Stacey Willard, PhD, Director of Product Management, IsoPlexis

What's Inside

In this Webinar we discuss:

Learn how our unique technology is playing a critical part in advancing cellular immunotherapy

Discover how IsoPlexis is changing the way cell therapies are developed & manufactured

Review several publications & case studies

awards-bar-3-wide-color-right
awards-bar-4-wide-color-left
Row rect Shape Decorative svg added to top
Watch the Webinar
Back to the Top